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The National Cancer Institute (NCI) plays a critically important role in providing vision and leadership 
for cancer research in the United States and around the world. Three decades ago the United States 
government recognized the importance of mobilizing an effort against cancer and passed the National 
Cancer Act. Since that time we have seen the success of transforming scientiﬁ  c discoveries into treat-
ments, illustrated by the fact that today there are over 10 million cancer survivors.
We are in the midst of an explosion of knowledge about cancer as a disease process. We are begin-
ning to understand cancer not by what we can see and touch – or by what is revealed under a microscope – 
but at the molecular level. It is not a question of if, but rather when and how, molecular medicine 
translates into personalized care. As we understand more completely the steps of the cancer process, 
we will identify the speciﬁ  c molecular targets in that process that are vulnerable to preemption. Based 
upon the realization of how much can be accomplished by coming together as teams and integrating 
our robust biomedical research enterprise, NCI has challenged the oncology community to eliminate 
the suffering and death due to cancer by 2015.
We cannot achieve this ambitious goal without greater interconnectivity and coordination across the 
cancer enterprise. This requires seeing cancer as a systems problem that will require a systems solution. 
Although cancer is being unraveled rapidly at the genomic and proteomic levels, we have not con-
comitantly developed the seamless system needed to capitalize on our discoveries.
To universally integrate personalized medicine into cancer prevention, diagnosis and treatment, 
researchers and clinicians must be able to gain rapid access to multiple types of speciﬁ  c information 
about an individual patient—information to which they do not currently have easy access. A new gen-
eration of medicine will require incorporation of shared information technologies (IT).
The information infrastructure revolution that has transformed business has had slow uptake in biol-
ogy and medicine. NCI is committed to creating a standards-based biomedical infrastructure and to 
making it available across the entire cancer enterprise. In 2003, NCI launched the cancer Biomedical 
Informatics Grid (caBIG™), an international collaboration to facilitate and enable research teams to 
share data, applications, and infrastructure that facilitate collaborations that accelerate the conversion 
of data from information to knowledge.
Within the cancer research community there exists a “Tower of Babel” problem. Research teams 
cannot easily understand data collected by—or share data with—other medical research teams working 
on the very same disease. Efﬁ  cient, effective collaborations are blocked by these “language” and data 
sharing problems. Scientists have a difﬁ  cult time integrating the various types of data they collect in a 
manner that will allow them to ask and answer important questions about how a disease works, and 
what they can do to stop it.
Medical research teams have operated, in effect, as cottage industries, each collecting and interpret-
ing data using a unique language of their own making and in virtual isolation from other teams. Bio-
medical informatics has the potential to be the powerful critical means to achieve the necessary degree 
of integration as it provides the mechanisms and tools to support standardized sharing, management 
and analysis of diverse data across the bench-to-bedside continuum and back.
Recognizing the transformational power of an interoperable biomedical informatics infrastructure to 
overcome these obstacles, caBIG™ is constructed around three interrelated areas of informatics:
  •   Bioinformatics provides cancer and biomedical researchers with tools, infrastructure and analytic 23
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methodologies necessary to manage and 
harvest insights from the large volumes of 
data generated by novel types of research 
such as molecular biology, genomics and 
proteomics.
  •   Medical or clinical informatics enables the 
management, analysis and dissemination 
of clinical and public health data, and 
includes the use of informatics infrastruc-
ture and applications such as clinical trial 
management systems, electronic health 
records, and cancer registries.
  •    Biomedical informatics, an innovative 
synergy between bioinformatics and clini-
cal informatics, offers infrastructure, tools, 
techniques and applications that bridge the 
two other areas and creates a mechanism 
that facilitates the sharing of data along the 
continuum from research bench to clinical 
bedside and back. It offers the prospect of 
integrating individual patient data from 
clinical care into the clinical research envi-
ronment, and back into clinical care or 
basic science research.
Utilizing these principles, caBIG™ is being 
created by the cancer research community, for the 
cancer research community. caBIG™’s software 
engineers are developing standardized data collec-
tion and data management tools that will allow 
laboratory and clinical researchers to integrate their 
own data more effectively, as well as to share data 
more easily with others. In addition, they are devel-
oping data analysis tools that will improve the 
speed and productivity of basic cancer research 
and clinical trials being conducted in the cancer 
community across the country, and around the 
world. In short, they are developing a “fully 
interoperable” IT network that will supercharge 
the entire ﬁ  eld of cancer research.
caBIG™ is being developed speciﬁ  cally to 
enable and accelerate the “bench-to-bedside-and-
back” cycle. It is a network of information and 
tools that will allow cancer researchers, clinicians, 
and patients to easily share, integrate, and analyze 
data from many different sources. Enabling seam-
less connections between the distinct areas of 
research and between the many necessary sources 
of information will facilitate the creation of a new 
era of faster, and more effective personalized care 
by interdisciplinary teams of cancer researchers 
and clinicians.
caBIG™ is being built on open source, open 
access, open development, and federation princi-
ples. Anyone can gain access to caBIG™ software 
(and its component parts) at no cost, modify it to 
suit his or her needs, and contribute to its ongoing 
development. Many organizations are working 
together to realize its full potential, including for-
profit companies that wish to “add value” to 
caBIG™ – i.e., enhance caBIG™’s function or 
ease of use – and lease or sell those improvements 
to interested caBIG™ users.
As an open source model, source code for all 
caBIG™ software tools is available to end-users. 
This approach is consistent with the philosophy 
supporting development of the “knowledge 
commons,” which is created and fed by free and 
open distribution of intellectual property on the 
internet. We share the goal of the Science Com-
mons, to encourage scientiﬁ  c innovation by making 
it easier for scientists, universities, and industries 
to use literature, data, and other scientiﬁ  c intel-
lectual property, and to share their knowledge with 
others. As is the case with the Science Commons, 
a recently established project of the on-line con-
servancy service known as the Creative Commons, 
caBIG™ will be engineered to function within 
current copyright and patent law to promote legal 
and technical mechanisms that remove barriers to 
sharing.
As the transforming power of an integrated 
infrastructure becomes more widely appreciated, 
an ever increasing number of stakeholders are 24
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examining their own environments and asking 
how they can build interconnecting links through 
caBIG™. The foundational components of 
caBIG™ are readily available as building blocks, 
connectors, and tools. These components have 
broad utility beyond the cancer community, 
because much of the information and processes 
associated with cancer prevention, care, and 
research share fundamental elements or approaches 
with other health challenges.
Sharing and integrating functional genomics 
and clinical trial data can improve cancer prevention 
and treatment beyond any one country. The burden 
of cancer is international. caBIG™ is collaborating 
with the National Cancer Research Institute in the 
United Kingdom to enable a richer analysis of 
complex relationships between, for example, pat-
terns of gene expression and prognosis or response 
to treatment.
When appropriately delivered and used, bio-
medical informatics will provide an interconnected 
web of information and tools that link together the 
multitude of participants involved in the cancer 
endeavor. Although caBIG™’s most important 
accomplishments and contributions still lie in the 
future, it has the power to redeﬁ  ne how cancer 
research is conducted and shared. caBIG™ is has-
tening the time when patients live with, rather than 
die from cancer.
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